Catalyst Wire Dossier Catalyst Wire Dossier

VERU-111

VERU-111 · Veru Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VERU-111, covering 2021-11-24 to 2024-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent [Phase 3]

See pricing